Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2012 (2012), Article ID 735906, 4 pages
Case Report

Hepatic Myelopathy in a Patient with Decompensated Alcoholic Cirrhosis and Portal Colopathy

Department of Medicine, B. L. Taneja Block, Maulana Azad Medical College and Associated Hospitals, Bahadur Shah Zafar Marg, New Delhi 110002, India

Received 4 October 2012; Accepted 27 November 2012

Academic Editors: G. H. Koek, H. H. Lin, D. Lorenzin, C. Miyabayashi, and H. Uchiyama

Copyright © 2012 Madhumita Premkumar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Leigh and W. I. Card, “Hepato-lenticular degeneration. A case associated with postero-lateral column degeneration,” Journal of Neuropathology & Experimental Neurology, vol. 8, pp. 318–346, 1949. View at Google Scholar
  2. L. Zieve, D. F. Mendelson, and M. Goepfert, “Shunt encephalomyelopathy. II. Occurrence of permanent myelopathy,” Annals of Internal Medicine, vol. 53, pp. 53–63, 1960. View at Google Scholar · View at Scopus
  3. I. A. Brown, Liver-Brain Relationships, Thomas Y Crowell, Springfield, 1957.
  4. S. M. Gospe Jr., R. D. Caruso, M. S. Clegg et al., “Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis,” Archives of Disease in Childhood, vol. 83, no. 5, pp. 439–442, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Pant, A. N. Bhargava, M. M. Singh et al., “Myelopathy in hepatic cirrhosis,” British Medical Journal, vol. 1, pp. 1064–1065, 1963. View at Google Scholar
  6. G. Mendoza, J. Marti-Fabregas, J. Kulisevsky, and A. Escartin, “Hepatic myelopathy: a rare complication of portacaval shunt,” European Neurology, vol. 34, no. 4, pp. 209–212, 1994. View at Google Scholar · View at Scopus
  7. J. Panicker, S. Sinha, A. B. Taly, S. Ravishankar, and G. R. Arunodaya, “Hepatic myelopathy: a rare complication following extrahepatic portal vein occlusion and lienorenal shunt,” Neurology India, vol. 54, no. 3, pp. 298–300, 2006. View at Google Scholar · View at Scopus
  8. J. V. Campellone, D. Lacomis, M. J. Giuliani, and F. J. Kroboth, “Hepatic myelopathy. Case report with review of the literature,” Clinical Neurology and Neurosurgery, vol. 98, no. 3, pp. 242–246, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Weissenborn, U. J. F. Tietge, M. Bokemeyer et al., “Liver transplantation improves hepatic myelopathy: evidence by three cases,” Gastroenterology, vol. 124, no. 2, pp. 346–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Nardone, T. Buratti, A. Oliviero, A. Lochmann, and F. Tezzon, “Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study,” Journal of Neurology, vol. 253, no. 1, pp. 81–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. G. Lefer and F. S. Vogel, “Encephalomyelopathy with hepatic cirrhosis following portosystemic venous shunts,” Archives of Pathology, vol. 93, no. 2, pp. 91–97, 1972. View at Google Scholar · View at Scopus
  12. M. Demirci, E. Tan, B. Elibol, G. Gedikoglu, and O. Saribas, “Spastic paraparesis associated with portal-systemic venous shunting due to congenital hepatic fibrosis,” Neurology, vol. 42, no. 5, pp. 983–985, 1992. View at Google Scholar · View at Scopus
  13. K. Mandal and N. Chopra, “Acute transverse myelitis following hepatitis E virus infection,” Indian Pediatrics, vol. 43, no. 4, pp. 365–366, 2006. View at Google Scholar · View at Scopus
  14. K. Sriram, S. K. Shankar, M. R. Boyd, and V. Ravindranath, “Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid-mediated neurodegeneration,” Journal of Neuroscience, vol. 18, no. 24, pp. 10287–10296, 1998. View at Google Scholar · View at Scopus
  15. V. Ravindranath, “Neurolathyrism: mitochondrial dysfunction in excitotoxicity mediated by L-β-oxalyl aminoalanine,” Neurochemistry International, vol. 40, no. 6, pp. 505–509, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Kincaid, “Myelitis and myelopathy,” in Clinical Neurology, R. J. Joynt, Ed., vol. 3, pp. 1–36, JB Lippincott Company, Philadelphia, Pa, USA, 1992. View at Google Scholar
  17. C. Counsell and C. Warlow, “Failure of presumed hepatic myelopathy to improve after liver transplantation,” Journal of Neurology Neurosurgery and Psychiatry, vol. 60, no. 5, p. 590, 1996. View at Google Scholar · View at Scopus
  18. R. Troisi, J. Debruyne, and B. De Hemptinne, “Improvement of hepatic myelopathy after liver transplantation,” The New England Journal of Medicine, vol. 340, no. 2, p. 151, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Caldwell, N. Werdinger, S. Jakab et al., “Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature,” Liver Transplantation, vol. 16, no. 7, pp. 818–826, 2010. View at Google Scholar
  20. H. S. Malhotra, V. K. Paliwal, M. K. Singh, and A. Agarwal, “Hepatic myelopathy: an unusual complication of advanced hepatic disease,” Annals of Neurosciences, vol. 14, no. 1, 2007. View at Google Scholar